New era of regenerative medicine for cardiovascular diseases

Hung-Fat Tse

doi:10.1160/TH10-06-0347

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2010; 104(01): 4-5
DOI: 10.1160/TH10-06-0347

Theme Issue Editorial

Schattauer GmbH

New era of regenerative medicine for cardiovascular diseases

Hung-Fat Tse

¹Cardiology Division, Department of Medicine, Queen Mary Hospital and Research Centre of Heart, Brain, Hormone and Healthy Ageing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, HKSAR, China

› Author Affiliations

Abstract

PDF Download

PDF (53 kb)

References

References
1 Yang G, Kong L, Zhao W. et al. Emergence of chronic non-communicable diseases in China. Lancet 2008; 372: 1697-1705.
2 Orlic D, Kajstura J, Chimenti S. et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705.
3 Siu CW, Liao SY, Liu Y. et al. Stem cells for myocardial repair. Thromb Haemost 2010; 104: 6-12.
4 Ransohoff KJ, Wu JC. Advances in cardiovascular molecular imaging for tracking stem cell therapy. Thromb Haemost 2010; 104: 13-22.
5 Boheler KR. Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration. Thromb Haemost 2010; 104: 23-29.
6 Kong M, Fadi A, Li RA. Translational potential of human embryonic and induced pluipotent stem cells for myocardial repair: Insights from experimental models. Thromb Haemost 2010; 104: 30-38.
7 Lian Q, Chow Y, Esteban MA. et al. Future perspective of induced pluripotent stem cell for diagnosis, drug screening and treatment of human diseases. Thromb Haemost 2010; 104: 39-44.